Schroder Investment Management Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $62M | Sell |
|
|||||
|
2024
Q3 | $67.7M | Buy |
|
|||||
|
2024
Q2 | $51.5M | Buy |
|
|||||
|
2024
Q1 | $42.8M | Sell |
|
|||||
|
2023
Q4 | $55.9M | Buy |
|
|||||
|
2023
Q3 | $29.7M | Sell |
|
|||||
|
2023
Q2 | $45.6M | Sell |
|
|||||
|
2023
Q1 | $51.2M | Buy |
|
|||||
|
2022
Q4 | $45.7M | Sell |
|
|||||
|
2022
Q3 | $40.8M | Buy |
|
|||||
|
2022
Q2 | $49M | Sell |
|
|||||
|
2022
Q1 | $59.4M | Sell |
|
|||||
|
2021
Q4 | $61.8M | Buy |
|
|||||
|
2021
Q3 | $42.8M | Sell |
|
|||||
|
2021
Q2 | $53.3M | Sell |
|
|||||
|
2021
Q1 | $44.9M | Buy |
|
|||||
|
2020
Q4 | $41.8M | Buy |
|
|||||
|
2020
Q3 | $23.8M | Sell |
|
|||||
|
2020
Q2 | $28.7M | Buy |
|
|||||
|
2020
Q1 | $17.3M | Buy |
|
|||||
|
2019
Q4 | $25.8M | Sell |
|
|||||
|
2019
Q3 | $10.7M | Sell |
|
|||||
|
2019
Q2 | $18.6M | Buy |
|
|||||
|
2019
Q1 | $16.5M | Buy |
|
|||||
|
2018
Q4 | $13.2K | Sell |
|
|||||
|
2018
Q3 | $26.1M | Buy |
|
|||||
|
2018
Q2 | $21.2M | Buy |
|